Fiscal Q1 2027 includes product-level net revenue from GRAFAPEX (treosulfan) for Injection of $4.9 million relative to $3.2 million of GRAFAPEX personnel and infrastructure investmentsCommercial tract ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results